Is Cipro HC still hard to find in 2026? Get the latest on Cipro HC availability, the new generic option, pricing updates, and how to find it in stock near you.
If you've tried to fill a Cipro HC prescription in the past few years, you may have run into empty shelves and back-ordered listings. For a medication that treats something as common as swimmer's ear, the availability challenges have been frustrating for patients and doctors alike.
So what's the situation in 2026? Here's everything you need to know about Cipro HC availability, the new generic, current pricing, and how to get your prescription filled.
Cipro HC is not formally listed on the FDA Drug Shortage database as of early 2026. However, "shortage" doesn't always mean an official FDA listing. For years, Cipro HC has had limited practical availability — meaning it existed on the market, but many pharmacies simply didn't stock it.
The root cause was simple: Cipro HC was a brand-only product from 1998 to December 2025 — over 27 years with zero generic competition. That meant high prices, limited distribution, and pharmacies preferring to stock cheaper alternatives instead.
For a deeper explanation, check out why Cipro HC has been so hard to find.
Several factors have contributed to Cipro HC's limited availability:
Without a generic option, Cipro HC's price stayed high — $350 to $480 per 10 mL bottle. Pharmacies that only fill a handful of Cipro HC prescriptions per month couldn't justify keeping such an expensive product in stock.
U.S. annual sales of Cipro HC were approximately $17.9 million (12 months ending September 2025, per IQVIA). For context, blockbuster drugs generate billions in annual revenue. A small market means fewer distributors, less supply chain attention, and more vulnerability to disruptions.
Faced with Cipro HC's availability issues, many doctors started prescribing alternatives like generic Ciprodex or Ofloxacin otic. This created a feedback loop: fewer prescriptions meant even less incentive for pharmacies to stock it.
The most significant development for Cipro HC patients in years happened in December 2025, when the FDA approved the first generic version of Cipro HC, manufactured by Cosette Pharmaceuticals.
Key facts about the new generic:
This is a game-changer. A lower-cost generic means pharmacies are more willing to stock it, insurers are more likely to cover it, and patients save hundreds of dollars per prescription.
Here's the current pricing landscape:
For a complete guide to reducing your costs, see How to Save Money on Cipro HC in 2026.
In 2026, you have more options than ever for treating an outer ear infection:
Ask your pharmacy specifically for the generic Ciprofloxacin/Hydrocortisone otic suspension. It's clinically equivalent to brand-name Cipro HC and costs a fraction of the price.
If your local pharmacy doesn't carry it, Medfinder can show you which pharmacies near you have Cipro HC or its generic in stock. For step-by-step instructions, see our guide on how to find Cipro HC in stock near you.
If Cipro HC still isn't available in your area, several effective alternatives exist:
See our full comparison in Alternatives to Cipro HC.
Here are the most effective strategies for finding Cipro HC today:
For more detailed tips, read How to Check If a Pharmacy Has Cipro HC in Stock.
The Cipro HC availability picture is genuinely improving in 2026. The arrival of the first generic in December 2025 is the most important development in over two decades for patients who need this medication. Prices are dropping, more pharmacies are stocking it, and insurance coverage is expanding.
If you need Cipro HC right now, start with Medfinder to find it in stock near you. Ask about the generic to save money. And if you still can't find it, talk to your doctor about effective alternatives — there are several good ones available. For more information about Cipro HC, explore our other guides:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
